Early research (Phase 1)Study completedNCT01008527What this trial is testingPhase I Oncovir Poly IC:LC and NY-ESO-1/gp100Who this might be right forMelanoma H. Lee Moffitt Cancer Center and Research Institute 22
Testing effectiveness (Phase 2)Ended earlyNCT00550654What this trial is testingConformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the BrainWho this might be right forKidney CancerMelanoma (Skin)Metastatic Cancer+3 more National Institutes of Health Clinical Center (CC) 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03122522What this trial is testingEvaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination ImmunotherapyWho this might be right forMetastatic Melanoma Memorial Sloan Kettering Cancer Center 70
Not applicableUnknownNCT00450593What this trial is testingIdentifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary MelanomaWho this might be right forHereditary Multiple MelanomaMelanoma (Skin) Leeds Cancer Centre at St. James's University Hospital 5,000
Testing effectiveness (Phase 2)Study completedNCT01840007What this trial is testingPilot Study Evaluating the Efficacy and Safety of Metformin in MelanomaWho this might be right forMetastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC) Centre Hospitalier Universitaire de Nice 20
Early research (Phase 1)Study completedNCT01638533What this trial is testingRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionWho this might be right forGliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269What this trial is testingThermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal CordWho this might be right forMalignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03999749What this trial is testingA Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV MelanomaWho this might be right forMelanoma NYU Langone Health 71
Testing effectiveness (Phase 2)Study completedNCT00004152What this trial is testingPET and CT Scans to Evaluate Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) Memorial Sloan Kettering Cancer Center
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT00350597What this trial is testingGM-CSF as Adjuvant Therapy of MelanomaWho this might be right forMalignant Melanoma Northern California Melanoma Center 50
Testing effectiveness (Phase 2)Study completedNCT00026520What this trial is testingInterferon Alfa and Thalidomide in Treating Patients With Stage IV MelanomaWho this might be right forMelanoma (Skin) SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT02073123What this trial is testingStudy of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic MelanomaWho this might be right forMetastatic MelanomaStage III MelanomaStage IV Melanoma NewLink Genetics Corporation 131
Testing effectiveness (Phase 2)Study completedNCT02158520What this trial is testingNab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by SurgeryWho this might be right forMetastatic MelanomaMucosal MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more Academic and Community Cancer Research United 24
Testing effectiveness (Phase 2)Study completedNCT02574260What this trial is testingAn Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016)Who this might be right forMelanoma BioVex Limited 3
Testing effectiveness (Phase 2)Ended earlyNCT00560118What this trial is testingFotemustine in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Institut du Cancer de Montpellier - Val d'Aurelle 12
Testing effectiveness (Phase 2)Study completedNCT00299689What this trial is testingPhase II Trial of Ontak With Metastatic MelanomaWho this might be right forMalignant Melanoma James Graham Brown Cancer Center 69
Early research (Phase 1)Study completedNCT01727076What this trial is testingRecombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerWho this might be right forHead and Neck Squamous Cell CarcinomaRecurrent Head and Neck CarcinomaRecurrent Non-Small Cell Lung Carcinoma+11 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00715793What this trial is testingCombination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic MelanomaWho this might be right forMalignant Melanoma Hussein Tawbi 39
Early research (Phase 1)Study completedNCT01738139What this trial is testingIpilimumab and Imatinib Mesylate in Advanced CancerWho this might be right forAdvanced Malignant Solid NeoplasmC-KIT Tyrosine Kinase Protein OverexpressionClinical Stage IV Cutaneous Melanoma AJCC v8+6 more M.D. Anderson Cancer Center 68